Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q1 2025 (March 31)5holders +1
1new positions
0sold out
$6.93avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($146K), Rhumbline Advisers ($88K) and PNC Financial Services Group, Inc. ($18K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 696 shares bought and 709 shares sold, net −13 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.01% | No change | 21,098 | $146K |
| Rhumbline Advisers | 0.00% | Reduce -5.3% | 12,740 | $88K |
| PNC Financial Services Group, Inc. | 0.00% | Add +20.4% | 2,593 | $18K |
| GAMMA Investing LLC | 0.00% | New | 256 | $2K |
| Brooklyn Investment Group | 0.00% | No change | 40 | $279 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.